A modified host-mediated assay system using cultured human lymphoid cells as target cells is described. The human cells were cultured in diffusion chambers (DC) and implanted into C 3H St mice. Induction of chromosome aberrations in human cells in DC as well as host bone marrow cells was used as an index of mutagenicity of a given compound and its metabolites. The cells from six human lymphoid lines were studied for their growth potential in DC in mice. Cells from two lines, both derived from blood of normal persons, failed to grow. The other four lines proliferated well. The maximum number of cells per DC was reached from 3 to 5 days after implantation and the maximum cell density per DC varied from 4 to 15 times the initial cell concentration. The mitotic index in DC was high on the first and second days and then decreased gradually. There were mitoses in some DC more than 2 weeks after implantation. Cells from DC which had been in hosts for approximately 2 weeks were recultured. Several such cultures proliferated within a week. Cytogenetic effects of cyclophosphamide (CY) in cells from two lines in DC in mice and in host bone marrow were investigated. A high rate of human and mouse cells with chromosome aberrations caused by CY injection was observed.
Read full abstract